Quick review: 160 varieties of drugs will be determined in the future! In three years!

On January 17, the second batch of national volume procurement will begin, and 33 varieties are ready to launch At this juncture, the author received the relevant industry news: the national level joint procurement target is to take the top 160 varieties of hospital procurement from high to low as the focus of future centralized procurement It is planned to carry out another three years and another five to six batches Considering that there are at least 25 varieties in each batch, mainly for those passing the consistency evaluation, at least three imitations of each variety will automatically start the national centralized purchase! According to the official external report of China Youth client, on January 10, the national medical security working conference was held in Beijing The meeting summarized the work of medical security in 2019, and studied and deployed the key tasks of medical security in 2020 The meeting stressed that in 2020, we will focus on seven aspects: first, we will increase preferential support to the areas with deep poverty, complete the task of poverty alleviation for the poor due to illness, and give full play to the basic function of the poverty alleviation policy of medical insurance Second, we should vigorously promote the reform of centralized purchasing and use of drugs organized by the state, break the barriers of interests, and realize normal operation, so as to promote the reform of "three medical linkage" Third, we will continue to work hard to crack down on fraud, improve relevant laws and systems, and establish and improve long-term mechanisms Fourth, we should establish a dynamic adjustment mechanism for the medical insurance drug catalog, further promote DRG pilot, and improve the medical insurance payment system Fifthly, we will do a good job in the implementation of the new negotiated drugs, the guarantee mechanism for the use of drugs in hypertension and diabetes clinics, the centralized purchase of drugs and medical consumables, and ensure that the reform results truly benefit the masses Sixthly, we will improve the capacity of public services, continue to promote the construction of business style, and comprehensively implement the "good and bad evaluation" system The seventh is to study and promote the direct settlement of outpatient service in different places in the regional integration area We will promote electronic vouchers for medical insurance and accelerate the construction of medical insurance information platforms and the implementation of coding standards According to the industry clues, the meeting stressed that "opinions on deepening the reform of medical security system" will be issued in the next step This opinion will be the highest and most important document in the history of China's medical insurance The development direction of the medical insurance system in the next decade will be covered in this opinion In addition, according to the industry clues, the National Health Insurance Bureau will take centralized mining as the breakthrough of the three medical linkage reform in the future The national centralized purchase plan is to focus on the first 160 varieties of hospital procurement from high to low It is planned to carry out another three years and another five to six batches Considering that there are at least 25 varieties in each batch, mainly for those passing the consistency evaluation, at least three imitations of each variety will automatically start the national centralized purchase Other unqualified varieties will be purchased by local organizations Although the national expansion of 4 + 7 in 2019 and the second batch of national joint mining that will start soon seem to focus only on 25 + 33 varieties, the actual radiation range has a huge impact As the author has analyzed before, for the industry, the first consideration should be given to the price relationship between the winning and the unsuccessful of national joint mining If some enterprises choose to win the bid, there are only two ways out for those who fail to win the bid: one is to follow the bid, make up for the lack of winning the bid, and compete in other markets Second, if we do not follow the provincial bid route, then it is the same consistency evaluation In the current environment, is it safer to use the winning varieties or the non winning varieties with higher prices?! In addition, provinces and cities will basically not leave high price space for unsuccessful products to survive Secondly, we should consider the competition between the unsuccessful varieties and the non evaluated varieties Many varieties that have not won the bid have been actively applied for price reduction in many provinces for several months According to the latest provincial policies, if the price of the varieties that have not passed the consistency evaluation is not consistent with the price, the price will be lowered That is to say, if it is implemented according to the rules of national centralized purchase, not only the price of the selected enterprises will be greatly reduced, but also the non selected varieties + related varieties that fail to pass the consistency evaluation + similar varieties in the same treatment field will suffer from the downward adjustment of the related price According to the above clues and official statements, the national level will form a seamless link with the local level: the national level will focus on finishing the top three varieties with large amount, large quantity and over rated quantity, while the other varieties will still be handed over to the provinces and cities for discussion The samples of volume purchasing and negotiation are basically executed according to the blue print of national volume purchasing On this basis, the provinces and cities make fine-tuning, but there will not be much change In the past, the bidding procurement of a province was often reduced by 10 points, so the enterprises could not bear it, such as the second batch of Zhejiang Province and Hunan bidding procurement Now according to this trend, if it is only 10 points lower, it is estimated that it is necessary to burn incense and pray for blessings The drop rate of about 20-30 points will basically become the standard match for provinces and cities to purchase with volume! For enterprises, the 2020 volume purchase not only tests the ability of price determination, but also the ability of strategic decision-making! That is: "the cognitive ability to evaluate the consistency of generic drugs + the enterprise's decision-making ability to the direction of development of the consistency of generic drugs + the product selection decision-making ability" Without these three capabilities, even in the future to carry out the volume of procurement in various regions barely winning the bid, what can be done? There is no good top-level planning, one day in a day, that might as well, in two years, we walk and see?! Now, enterprises have organized annual meetings and sales conferences, sincerely hope that while encouraging morale, they should also have the sense of anxiety of the whole staff, thoroughly discuss the problems in 2020, and think more deeply Only in this way, they will not panic when confronted with the challenge of volume purchasing The purpose of the annual meeting is to look back on the past and look into the future It must not be confused by the victory for a while It has entered 2020 How to deal with the coming storm of purchasing with volume is the most urgent thing 37 statement: This article only represents the author and does not represent the position of yaozhi.com You are welcome to communicate and supplement in the message area If you need to reprint, please be sure to indicate the author and source of the article.